H N Sather

1.7k total citations
22 papers, 1.2k citations indexed

About

H N Sather is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Genetics. According to data from OpenAlex, H N Sather has authored 22 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Public Health, Environmental and Occupational Health, 9 papers in Pediatrics, Perinatology and Child Health and 7 papers in Genetics. Recurrent topics in H N Sather's work include Acute Lymphoblastic Leukemia research (17 papers), Childhood Cancer Survivors' Quality of Life (8 papers) and Glioma Diagnosis and Treatment (5 papers). H N Sather is often cited by papers focused on Acute Lymphoblastic Leukemia research (17 papers), Childhood Cancer Survivors' Quality of Life (8 papers) and Glioma Diagnosis and Treatment (5 papers). H N Sather collaborates with scholars based in United States and Switzerland. H N Sather's co-authors include G. Denman Hammond, M E Nesbit, L. L. Robison, James B. Nachman, P S Gaynon, John N. Lukens, Martha G. Sensel, Peter G. Steinherz, Lawrence J. Wolff and W. Archie Bleyer and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

H N Sather

22 papers receiving 1.2k citations

Peers

Countries citing papers authored by H N Sather

Since Specialization

Citations

This map shows the geographic impact of H N Sather's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H N Sather with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H N Sather more than expected).

Fields of papers citing papers by H N Sather

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H N Sather. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H N Sather. The network helps show where H N Sather may publish in the future.

Co-authorship network of co-authors of H N Sather

This figure shows the co-authorship network connecting the top 25 collaborators of H N Sather. A scholar is included among the top collaborators of H N Sather based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H N Sather. H N Sather is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Residual bone marrow leukemic progenitor cell burden after induction chemotherapy in pediatric patients with acute lymphoblastic leukemia. 2000 ·PubMed ·Fatih M. Uckun, Linda C. Stork, Nita L. Seibel, (unknown), (unknown), H N Sather, Martha G. Sensel, Gregory H. Reaman, Paul S. Gaynon	3
2	Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children's Cancer Group. 1998 ·Journal of Clinical Oncology ·James B. Nachman, H N Sather, Joel M. Cherlow, Martha G. Sensel, P S Gaynon, John N. Lukens, Lawrence J. Wolff, ME Trigg	92
3	Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: a report from the Children's Cancer Group. 1998 ·Journal of Clinical Oncology ·Fatih M. Uckun, Martha G. Sensel, H N Sather, P S Gaynon, DC Arthur, Beverly J. Lange, Peter G. Steinherz, Peter Kraft, Raymond J. Hutchinson, James B. Nachman, Gregory H. Reaman, NA Heerema	100
4	Frequency and clinical significance of cytogenetic abnormalities in pediatric T-lineage acute lymphoblastic leukemia: a report from the Children's Cancer Group. 1998 ·Journal of Clinical Oncology ·Nyla A. Heerema, H N Sather, Martha G. Sensel, Peter Kraft, James B. Nachman, Peter G. Steinherz, Beverly J. Lange, (unknown), Gregory H. Reaman, M Trigg, DC Arthur, Paul S. Gaynon, Fatih M. Uckun	81
5	#672 Oral 6-thioguanine (TG) causes relatively mild and reversible hepatic venoocclusive disease (VOD) 1998 ·Journal of Pediatric Hematology/Oncology ·Linda C. Stork, (unknown), Philip D Adamson, Bruce Bostrom, Yousif Matloub, (unknown), (unknown), John F. Kelleher, Margaret Masterson, Robert S. Ettinger, H N Sather, P S Gaynon	11
6	Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report from the Children's Cancer Group. 1997 ·Journal of Clinical Oncology ·James B. Nachman, H N Sather, P S Gaynon, John N. Lukens, Lawrence J. Wolff, M Trigg	89
7	Clinical features and treatment outcome of childhood T-lineage acute lymphoblastic leukemia according to the apparent maturational stage of T-lineage leukemic blasts: a Children's Cancer Group study. 1997 ·Journal of Clinical Oncology ·Fatih M. Uckun, P S Gaynon, Martha G. Sensel, James B. Nachman, ME Trigg, Peter G. Steinherz, Ray Hutchinson, Bruce Bostrom, H N Sather, G H Reaman	81
8	Epidemiological characteristics of childhood acute lymphocytic leukemia. Analysis by immunophenotype. The Childrens Cancer Group. 1994 ·PubMed ·Jonathan D. Buckley, (unknown), Kathleen S. Ruccione, H N Sather, Mary J. Waskerwitz, William G. Woods, Leslie L. Robison	68
9	A comparison of four staging systems for localized and regional neuroblastoma: a report from the Childrens Cancer Study Group. 1990 ·Journal of Clinical Oncology ·Audrey E. Evans, Giulio J. D’Angio, H N Sather, Alfred A. de Lorimier, (unknown), Richard S. Ungerleider, Jerry Z. Finklestein, G. Denman Hammond	37
10	Effects of radiation on testicular function in long-term survivors of childhood acute lymphoblastic leukemia: a report from the Children Cancer Study Group. 1990 ·Journal of Clinical Oncology ·Charles A. Sklar, L. L. Robison, M E Nesbit, H N Sather, Anna T. Meadows, Jorge A. Ortega, (unknown), G. Denman Hammond	89
11	Interferon-αnl in Children with Recurrent Acute Lymphocytic Leukemia: A Phase I Study of Pharmacokinetics and Tolerance 1988 ·Journal of Interferon Research ·Robert J. Wells, Phillip K. Weck, RL Baehner, William Krivit, R. Beverly Raney, José Antonio Ortega, (unknown), (unknown), John K. Whisnant, H N Sather, (unknown)	7
12	INTENSIVE THERAPY FOR CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKAEMIA AND UNFAVOURABLE PRESENTING FEATURES 1988 ·The Lancet ·(unknown), W. Archie Bleyer, (unknown), (unknown), (unknown), G H Reaman, P. Steinherz, (unknown), (unknown), (unknown), (unknown), H N Sather, G. Denman Hammond	100
13	The effect of initial management of hyperleukocytosis on early complications and outcome of children with acute lymphoblastic leukemia. 1988 ·Journal of Clinical Oncology ·(unknown), Peter G. Steinherz, Paul S. Gaynon, J Z Finklestein, H N Sather, G H Reaman, W. Archie Bleyer, G. Denman Hammond	51
14	Long-term evaluation of a CNS prophylaxis trial--treatment comparisons and outcome after CNS relapse in childhood ALL: a report from the Childrens Cancer Study Group. 1987 ·Journal of Clinical Oncology ·José Antonio Ortega, M E Nesbit, H N Sather, L. L. Robison, G J D'Angio, G. Denman Hammond	39
15	Improved survival of infants less than 1 year of age with acute lymphoblastic leukemia treated with intensive multiagent chemotherapy. 1987 ·PubMed ·Gregory H. Reaman, P. Steinherz, P S Gaynon, W. Archie Bleyer, J Z Finklestein, Rachel Evans, (unknown), H N Sather, G. Denman Hammond	26
16	PROGNOSTIC IMPORTANCE OF SERUM FERRITIN IN PATIENTS WITH STAGES III AND IV NEUROBLASTOMA: THE CHILDREN CANCER STUDY GROUP EXPERIENCE 1985 ·(unknown), Andrea Evans, (unknown), H N Sather, (unknown)	11
17	Reduction in central nervous system leukemia with a pharmacokinetically derived intrathecal methotrexate dosage regimen. 1983 ·Journal of Clinical Oncology ·W. Archie Bleyer, Peter F. Coccia, H N Sather, (unknown), John N. Lukens, (unknown), S E Siegel, (unknown), Sanford Leikin, Donald R. Miller	92
18	PRESYMPTOMATIC CENTRAL NERVOUS SYSTEM THERAPY IN PREVIOUSLY UNTREATED CHILDHOOD ACUTE LYMPHOBLASTIC LEUKAEMIA: COMPARISON OF 1800 RAD AND 2400 RAD 1981 ·The Lancet ·M E Nesbit, L. L. Robison, (unknown), H N Sather, Jorge E. Ortega, (unknown), G. Denman Hammond	118
19	COMPARISON OF THREE METHODS OF CENTRAL-NERVOUS-SYSTEM PROPHYLAXIS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKÆMIA 1980 ·The Lancet ·(unknown), (unknown), H N Sather, (unknown), M E Nesbit, J. Robert Cassady, L. Sinks, Denman Hammond, Emil Frei	44
20	Radiation therapy (RT) factors in prophylactic central nervous system (CNS) irradiation for childhood leukemia 1979 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), G J D'Angio, M E Nesbit, H N Sather, (unknown), Milton H. Donaldson, D Hammond	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact